The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kovalenko Yu.A.

Vishnevsky National Research Center of Surgery, Moscow, Russia

Makarchev A.D.

Vishnevsky National Research Center of Surgery, Moscow, Russia

Muhtarov O.Ya.

Vishnevsky National Research Center of Surgery, Moscow, Russia

Shevchenko T.V.

Vishnevsky National Research Center of Surgery, Moscow, Russia

Ruzavin V.S.

Vishnevsky National Research Center of Surgery, Moscow, Russia

Gurmikov B.N.

Vishnevsky National Research Center of Surgery, Moscow, Russia

Long-term postoperative outcomes in patients with hilar cholangiocarcinoma: a single-center experience

Authors:

Kovalenko Yu.A., Makarchev A.D., Muhtarov O.Ya., Shevchenko T.V., Ruzavin V.S., Gurmikov B.N.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2026;(3): 18‑24

Read: 773 times


To cite this article:

Kovalenko YuA, Makarchev AD, Muhtarov OYa, Shevchenko TV, Ruzavin VS, Gurmikov BN. Long-term postoperative outcomes in patients with hilar cholangiocarcinoma: a single-center experience. Pirogov Russian Journal of Surgery. 2026;(3):18‑24. (In Russ.)
https://doi.org/10.17116/hirurgia202603118

Recommended articles:

References:

  1. Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C,... Gores GJ. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Rev Gastroenterol Hepatol. 2020;17(9):557-588.  https://doi.org/10.1038/s41575-020-0310-z
  2. Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost’ i smertnost’) pod red. A.D. Kaprin i dr. Moskva. 2022. (In Russ.).
  3. Cardinale V. Classifications and misclassification in cholangiocarcinoma. Liver Int. 2019;39(2):260-262.  https://doi.org/10.1111/liv.13998
  4. Van Keulen AM, Franssen S, van der Geest LG, de Boer MT, Coenraad M, van Driel LMJW, Erdmann JI, Haj Mohammad N, Heij L, et al. Nationwide treatment and outcomes of perihilar cholangiocarcinoma. Liver Int. 2021;41:1945-1953.
  5. Sharma P, Yadav S. Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors. Ann Gastroenterol. 2018;31(2):231-236.  https://doi.org/10.20524/aog.2018.0233
  6. Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28(3):226-231.  https://doi.org/10.1159/000327361
  7. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, Bresadola F, Calise F, Dalla Valle R, D’Amico DF, Gennari L, Giulini SM, Guglielmi A, Jovine E, Pellicci R, Pernthaler H, Pinna AD, Puleo S, Torzilli G, Capussotti L; Italian Chapter of the International Hepato-Pancreato-Biliary Association; Cillo U, Ercolani G, Ferrucci M, Mastrangelo L, Portolani N, Pulitanò C, Ribero D, Ruzzenente A, Scuderi V, Federico B. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147(1):26-34.  https://doi.org/10.1001/archsurg.2011.771
  8. Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach. Surgery. 2018;163(4):732-738.  https://doi.org/10.1016/j.surg.2017.08.011
  9. Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MGH, Blumgart LH, Busch ORC, D’Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol. 2015;26(9):1930-1935. https://doi.org/10.1093/annonc/mdv279
  10. Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma. Ann Surg. 2021;273(3):572-578.  https://doi.org/10.1097/SLA.0000000000003305
  11. Roos E, Hubers LM, Coelen RJS, Doorenspleet ME, de Vries N, Verheij J, Beuers U, van Gulik TM. IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: a 30-Year Tertiary Care Experience. Am J Gastroenterol. 2018;113(5):765-772.  https://doi.org/10.1038/s41395-018-0036-5
  12. Chatelain D, Farges O, Fuks D, Trouillet N, Pruvot FR, Regimbeau JM. Assessment of pathology reports on hilar cholangiocarcinoma: the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. J Hepatol. 2012;56(5):1121-1128. https://doi.org/10.1016/j.jhep.2011.12.010
  13. Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma. Ann Surg Oncol. 2021;28(3):1493-1498. https://doi.org/10.1245/s10434-020-09105-1
  14. D’Souza MA, Al-Saffar HA, Fernández Moro C, Shtembari S, Danielsson O, Sparrelid E, Sturesson C. Redefining resection margins and dissection planes in perihilar cholangiocarcinoma-radical resection is a rare event. Virchows Arch. 2022;480(3):557-564.  https://doi.org/10.1007/s00428-021-03231-1
  15. Kovalenko YA, Zharikov YO, Konchina NA, Gurmikov BN, Marinova LA, Zhao AV. Perihilar cholangiocarcinoma: A different concept for radical resection. Surg Oncol. 2020;33:270-275.  https://doi.org/10.1016/j.suronc.2020.02.013
  16. Cillo U, Fondevila C, Donadon M, Gringeri E, Mocchegiani F, Schlitt HJ, Ijzermans JNM, Vivarelli M, Zieniewicz K, Olde Damink SWM, Groot Koerkamp B. Surgery for cholangiocarcinoma. Liver Int. 2019;39 Suppl 1(Suppl Suppl 1):143-155.  https://doi.org/10.1111/liv.14089
  17. Bengmark S, Ekberg H, Evander A, Klofver-Stahl B, Tranberg KG. Major liver resection for hilar cholangiocarcinoma. Ann Surg. 1988;207(2):120-125.  https://doi.org/10.1097/00000658-198802000-00002
  18. Boerma EJ. Research into the results of resection of hilar bile duct cancer. Surgery. 1990;108(3):572-580. 
  19. Zharikov YuO, Shevchenko TV, Zhao AV. Biliary decompression for tumors of the proximal bile ducts. Clinical Medicine. 2015;9.  https://cyberleninka.ru/article/n/biliarnaya-dekompressiya-pri-opuholyah-proksimalnyh-zhelchnyh-protokov(dateaccessed:07.05.2024).
  20. Shcherba AE, Slobodin YuV, Rummo OO, Avdey EL, Fedoruk AM, Kharkov DP, Korotkov S.V. Surgical treatment of Klatskin tumor. Surgical news. 2009;4.  URL:https://cyberleninka.ru/article/n/hirurgicheskoe-lechenie-opuholi-klatskina(dateaccessed:07.05.2024)
  21. Jonas S, Benckert C, Thelen A, Lopez-Hänninen E, Rösch T, Neuhaus P. Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol. 2008;34(3):263-2671. https://doi.org/10.1016/j.ejso.2007.09.024
  22. Ramacciato G, Nigri G, Bellagamba R, Petrucciani N, Ravaioli M, Cescon M, Del Gaudio M, Ercolani G, Di Benedetto F, Cautero N, Quintini C, Cucchetti A, Lauro A, Miller C, Pinna AD. Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg. 2010;76(11):1260-1268.
  23. Rea DJ, Munoz-Juarez M, Farnell MB, Donohue JH, Que FG, Crownhart B, Larson D, Nagorney DM. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139(5):514-23; discussion 523-5.  https://doi.org/10.1001/archsurg.139.5.514
  24. Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244(2):230-239.  https://doi.org/10.1097/01.sla.0000217639.10331.47
  25. Gazzaniga GM, Ciferri E, Bagarolo C, Filauro M, Bondanza G, Fazio S, Ermili F. Primitive hepatic hilum neoplasm. J Surg Oncol Suppl. 1993;3:140-146.  https://doi.org/10.1002/jso.2930530537
  26. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14(4):535-543; discussion 544.  https://doi.org/10.1007/BF01658686
  27. Ogura Y, Mizumoto R, Tabata M, Matsuda S, Kusuda T. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg. 1993;17(1):85-92; discussion 92-3.  https://doi.org/10.1007/BF01655714
  28. Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17(5):913-124.  https://doi.org/10.1007/s11605-013-2144-2.
  29. Sugiura Y, Nakamura S, Iida S, Hosoda Y, Ikeuchi S, Mori S, Sugioka A, Tsuzuki T. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery. 1994;115(4):445-451. 
  30. Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma. Ann Surg. 2021;273(3):572-578.  https://doi.org/10.1097/SLA.0000000000003305
  31. De Bellis M, Mastrosimini MG, Conci S, Pecori S, Campagnaro T, Castelli C, Capelli P, Scarpa A, Guglielmi A, Ruzzenente A. The Prognostic Role of True Radical Resection in Perihilar Cholangiocarcinoma after Improved Evaluation of Radial Margin Status. Cancers (Basel). 2022;14(24):6126. https://doi.org/10.3390/cancers14246126

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.